Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

A Northcott

Showing results (161-170 of 223) with videos related to

Pageof 23
Sort By:
Nature Genetics|March 10, 2009
Multiple recurrent genetic events converge on control of histone lysine methylation in medulloblastomaPaul A Northcott, Yukiko Nakahara, Xiaochong Wu, et al.
Oncotarget|April 9, 2016
Medulloblastoma-associated DDX3 variant selectively alters the translational response to stressSekyung Oh, Ryan A Flynn, Stephen N Floor, et al.
Nature|September 21, 2022
Unified rhombic lip origins of group 3 and group 4 medulloblastomaKyle S Smith, Laure Bihannic, Brian L Gudenas, et al.
Nature Genetics|November 22, 2016
Pan-cancer analysis of somatic copy-number alterations implicates IRS4 and IGF2 in enhancer hijackingJoachim Weischenfeldt, Taronish Dubash, Alexandros P Drainas, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|June 10, 2021
Children's Oncology Group Phase III Trial of Reduced-Dose and Reduced-Volume Radiotherapy With Chemotherapy for Newly Diagnosed Average-Risk MedulloblastomaJeff M Michalski, Anna J Janss, L Gilbert Vezina, et al.
Cancer Cell|March 6, 2026
A tumor-associated photoreceptor signature unifies distinct central nervous system malignanciesBrian L Gudenas, Shiekh Tanveer Ahmad, Bernhard Englinger, et al.
Nature Cancer|February 17, 2026
M-PACT leverages cell-free DNA methylomes to achieve robust classification of pediatric brain tumorsKyle S Smith, Tom T Fischer, Katie Han, et al.
Cancer Cell|September 12, 2018
Proteomics, Post-translational Modifications, and Integrative Analyses Reveal Molecular Heterogeneity within Medulloblastoma SubgroupsTenley C Archer, Tobias Ehrenberger, Filip Mundt, et al.
Acta Neuropathologica|February 23, 2021
Clinical and molecular heterogeneity of pineal parenchymal tumors: a consensus studyAnthony P Y Liu, Bryan K Li, Elke Pfaff, et al.
Cell|October 22, 2013
Hypermutation of the inactive X chromosome is a frequent event in cancerNatalie Jäger, Matthias Schlesner, David T W Jones, et al.
Pageof 23

Showing results (161-170 of 223) with videos related to

Sort By:
Pageof 23
Nature Genetics|March 10, 2009
Multiple recurrent genetic events converge on control of histone lysine methylation in medulloblastomaPaul A Northcott, Yukiko Nakahara, Xiaochong Wu, et al.
Oncotarget|April 9, 2016
Medulloblastoma-associated DDX3 variant selectively alters the translational response to stressSekyung Oh, Ryan A Flynn, Stephen N Floor, et al.
Nature|September 21, 2022
Unified rhombic lip origins of group 3 and group 4 medulloblastomaKyle S Smith, Laure Bihannic, Brian L Gudenas, et al.
Nature Genetics|November 22, 2016
Pan-cancer analysis of somatic copy-number alterations implicates IRS4 and IGF2 in enhancer hijackingJoachim Weischenfeldt, Taronish Dubash, Alexandros P Drainas, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|June 10, 2021
Children's Oncology Group Phase III Trial of Reduced-Dose and Reduced-Volume Radiotherapy With Chemotherapy for Newly Diagnosed Average-Risk MedulloblastomaJeff M Michalski, Anna J Janss, L Gilbert Vezina, et al.
Cancer Cell|March 6, 2026
A tumor-associated photoreceptor signature unifies distinct central nervous system malignanciesBrian L Gudenas, Shiekh Tanveer Ahmad, Bernhard Englinger, et al.
Nature Cancer|February 17, 2026
M-PACT leverages cell-free DNA methylomes to achieve robust classification of pediatric brain tumorsKyle S Smith, Tom T Fischer, Katie Han, et al.
Cancer Cell|September 12, 2018
Proteomics, Post-translational Modifications, and Integrative Analyses Reveal Molecular Heterogeneity within Medulloblastoma SubgroupsTenley C Archer, Tobias Ehrenberger, Filip Mundt, et al.
Acta Neuropathologica|February 23, 2021
Clinical and molecular heterogeneity of pineal parenchymal tumors: a consensus studyAnthony P Y Liu, Bryan K Li, Elke Pfaff, et al.
Cell|October 22, 2013
Hypermutation of the inactive X chromosome is a frequent event in cancerNatalie Jäger, Matthias Schlesner, David T W Jones, et al.
Pageof 23